Pregabalin add-on for drug-resistant focal epilepsy

This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1 Introduction Approximately 3–3.5% of Australians will experience epilepsy at some point...

PSA NT/SA Branch’s vaccine advocacy work

The PSA SA/NT Branch is fighting for pharmacists to be able to administer more vaccines. Read more about it here.

Blockchain exec pushing for the end of paper prescriptions

Australian laws requiring use of paper documents prevent new technological solutions that could inhibit prescription fraud. That’s the diagnosis of Dr Tal Rapke, chief executive...

Listings for biosimilar uptake drivers expanded

Amended prescribing information has been released for two biosimilar uptake drivers listed on the Pharmaceutical Benefits Scheme (PBS), as part of the Biosimilar Awareness...

Digital transformation with My Health Record

Pharmacists should be actively contributing to patients' My Health Record (MHR) in order to unlock the full potential of digital transformation, said Dr Kenneth...

Medicine safety: The big picture

Dr Libby Roughead MPS is Senior Principal Research Fellow at the University of South Australia’s School of Pharmacy, where her work focuses on quantifying...